Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5 , Pages 741-744 , May 2009

Accuracy of Manual Needle Placement for Gastrocnemius Muscle in Children With Cerebral Palsy Checked Against Ultrasonography

References 

  1. Cosgrove A, Corry I, Graham H. Botulinum toxin in the management of lower limb in cerebral palsy. Dev Med Child Neurol. 1994;36:386–396
  2. Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 2000;137:331–337
  3. Berweck S, Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F. Sonography-guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics. 2002;33:221–223
  4. Zurcher AW, Molenaers G, Desloovere K, Fabry G. Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin A in children with cerebral palsy. Acta Orthop Belg. 2001;67:475–480
  5. Metaxiotis D, Siebel A, Doederlein L. Repeated botulinum toxin A injections in the treatment of spastic equinus foot. Jan Clin Orthop Relat Res. 2002;(394):177–185
  6. Polak F, Morton R, Ward C, Wallace WA, Doederlein L, Siebel A. Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol. 2002;44:551–555
  7. Gage J. Cerebral-palsied gait. In:  Gage JR editors. Gait analysis in cerebral palsy. London: MacKeith Pr; 1991;
  8. Satila H, Iisalo T, Pietikainen T, et al. Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites. Am J Phys Med Rehabil. 2005;84:355–365quiz 66-7, 92
  9. Scholtes VA, Dallmeijer AJ, Knol DL, et al. Effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol. 2007;36:30–39
  10. Boyd R, Graham H. Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. Eur J Neurol. 1997;4(Suppl 2):15–22
  11. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol. 1997;39:185–193
  12. Koman L, Mooney J, Smith B. Management of cerebral palsy with botulinum A toxin: preliminary investigation. J Pediatr Orthop. 1993;13:489–495
  13. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Phys Med Rehabil. 2003;82:284–289
  14. Autti-Rämo I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol. 2001;8(Suppl 5):136–144
  15. Moore P, Naumann M. General and clinical aspects of treatment with botulinum toxin. Oxford: Blackwell Science; 2003;
  16. O'Brien C. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve Suppl. 1997;6:S176–S180
  17. Willenborg MJ, Shilt JS, Smith BP, Estrada RL, Castle JA, Koman LA. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J Pediatr Orthop. 2002;22:165–168
  18. Ajax T, Ross MA, Rodnitzky RL. The role of electromyography in guiding botulinum toxin injections for focal dystonia and spasticity. J Neurol Rehabil. 1998;12:1–4
  19. Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992;42:878–882
  20. Ibrahim AI, Hawamdeh ZM, Al-Qudah AA. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children. Eura Medicophys. 2007;43:13–20
  21. De Paiva A, Dolly J. Light-chain of botulinum neurotoxin is active in mammalian nerve terminals when delivered by liposomes. FEBS Lett. 1990;277:171–174
  22. Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop. 2005;25:286–291
  23. Lampe R, Grassl S, Mitternacht J, Gerdesmeyer L, Gradinger R. MRT-measurements of muscle volumes of the lower extremities of youths with spastic hemiplegia caused by cerebral palsy. Brain Dev. 2006;28:500–506
  24. Mohagheghi AA, Khan T, Meadows TH, Giannikas K, Baltzopoulos V, Maganaris CN. Differences in gastrocnemius muscle architecture between the paretic and non-paretic legs in children with hemiplegic cerebral palsy. Clin Biomech (Bristol, Avon). 2007;22:718–724
  25. Malaiya R, McNee AE, Fry NR, Eve LC, Gough M, Shortland AP. The morphology of the medial gastrocnemius in typically developing children and children with spastic hemiplegic cerebral palsy. J Electromyogr Kinesiol. 2007;17:657–663
  26. Berweck S, Heinen F. Treatment of cerebral palsy with botulinum toxin principles, clinical practices, atlas. Bonn: Child & Brain; 2003;
  27. Brin M. Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve. 1997;6:S208–S220
  28. Graham HK. Botulinum toxin A in cerebral palsy: functional outcomes. J Pediatr. 2000;137:300–303
  29. Childers MK, Stacy M, Cooke DL, Stonnington HH. Comparison of two injection techniques using botulinum toxin in spastic hemiplegia. Am J Phys Med Rehabil. 1996;75:462–469
  30. Satila HK, Pietikainen T, Lehtonen-Raty P, Koivikko M, Autti-Ramo I. Treatment of spastic equinus gait with botulinum toxin A: does dose matter? (Analysis of a clinical cohort). Neuropediatrics. 2006;37:344–349
  31. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 1999;10:1–9
  32. Fry NR, Gough M, McNee AE, Shortland AP. Changes in the volume and length of the medial gastrocnemius after surgical recession in children with spastic diplegic cerebral palsy. J Pediatr Orthop. 2007;27:769–774

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.

 Reprints are not available from the author.

PII: S0003-9993(09)00073-2

doi: 10.1016/j.apmr.2008.10.025

Archives of Physical Medicine and Rehabilitation
Volume 90, Issue 5 , Pages 741-744 , May 2009

Article Tools

* Image Usage & Resolution